|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
FY2019
12 months to Sep 30, 2019
|
FY2018
12 months to Sep 30, 2018
|
FY2017
12 months to Sep 30, 2017
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research, development and technical | |||||
| Selling, general and administrative | |||||
| Impairment charges | |||||
| Total operating expenses | |||||
| Operating (loss) income | |||||
| Interest expense, net | |||||
| Interest income | |||||
| Other expense, net | |||||
| (Loss) income before income taxes | |||||
| Provision for income taxes | |||||
| Net (loss) income | |||||
| Basic (loss) earnings per share (in dollars per share) | |||||
| Diluted (loss) earnings per share (in dollars per share) | |||||
| Weighted average basic shares outstanding (in shares) | |||||
| Weighted average diluted shares outstanding (in shares) | |||||
Loading...